{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:43:01Z","timestamp":1792194181489,"version":"4.4.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Dermatol Online J"],"published-print":{"date-parts":[[2021]]},"DOI":"10.4103\/idoj.idoj_513_21","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T04:50:50Z","timestamp":1637815850000},"page":"24","source":"Crossref","is-referenced-by-count":7,"title":["Updates on management of leprosy in the context of COVID-19 pandemic: Recommendations by IADVL SIG Leprosy"],"prefix":"10.4103","volume":"12","author":[{"given":"Tarun","family":"Narang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SunilKumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujai","family":"Suneetha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swetalina","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swastika","family":"Suvirya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankan","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrata","family":"Chhabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AngooriGnaneshwar","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PK","family":"Ashwini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar","family":"Jandhyala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santoshdev","family":"Rathod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PNarasimha","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Dogra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2229-5178.331156-1","first-page":"345","article-title":"Management of leprosy in the context of COVID-19 pandemic: Recommendations by SIG leprosy (IADVL Academy)","author":"Rathod","year":"2020","journal-title":"Indian Dermatol Online J","ISSN":"https:\/\/id.crossref.org\/issn\/2229-5178","issn-type":"print"},{"key":"key-10.4103\/2229-5178.331156-2","unstructured":"India's daily COVID-19 cases pass 400,000 for the first time as second wave worsens. Available from: https:\/\/www.reuters.com\/world\/asia-pacific\/indi a-posts-record-daily-rise-covid-19-cases -401993-2021-05-01\/. [Last accessed on 2021 Jul 25]."},{"key":"key-10.4103\/2229-5178.331156-3","doi-asserted-by":"crossref","unstructured":"de Barros B, Lambert SM, Negera E, de Arquer GR, Sales AM, Darlong J, et al. An assessment of the reported impact of the COVID-19 pandemic on leprosy services using an online survey of practitioners in leprosy referral centres. Trans R Soc Trop Med Hyg 2021;trab084. doi: 10.1093\/trstmh\/trab084.","DOI":"10.1093\/trstmh\/trab084"},{"key":"key-10.4103\/2229-5178.331156-4","unstructured":"WHO. COVID-19: WHO issues interim guidance for implementation of NTD programmes 2020, April 1. Available from: https:\/\/www.who.int\/neglected_diseases\/news\/COVID19 -WHO-interim-guidance-implementation-NTD-programmes\/ en\/. [Last accessed on 2021 Jul 25]."},{"key":"key-10.4103\/2229-5178.331156-5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/00333549101250S308","article-title":"\u201cDestroyer and teacher\u201d: Managing the masses during the 1918-1919 influenza pandemic","author":"Tomes","year":"2010","journal-title":"Public Health Rep"},{"key":"key-10.4103\/2229-5178.331156-6","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/all.14657","article-title":"Risk factors for severe and critically ill COVID-19 patients: A review","author":"Gao","year":"2021","journal-title":"Allergy"},{"key":"key-10.4103\/2229-5178.331156-7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.vaccine.2020.11.078","article-title":"Epidemiology of COVID-19 infection in young children under five years: A systematic review and meta-analysis","author":"Bhuiyan","year":"2021","journal-title":"Vaccine"},{"key":"key-10.4103\/2229-5178.331156-8","unstructured":"World Health Organization. Weekly Epidemiological Record, 2020;95 (36): 417-440. Available at https:\/\/apps.who.int\/iris\/handle\/10665\/334140. [Last accessed on 2021 Jul 26]."},{"key":"key-10.4103\/2229-5178.331156-9","doi-asserted-by":"crossref","first-page":"e0008460","DOI":"10.1371\/journal.pntd.0008460","article-title":"Will cases of leprosy reaction increase with COVID-19 infection?","author":"Antunes","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.4103\/2229-5178.331156-10","first-page":"e1","article-title":"Clinical characteristics and outcomes in patients with COVID-19 and leprosy","author":"Santos","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/2229-5178.331156-11","unstructured":"Pai VV, Wakade A. Leprosy and COVID-19 Co-infection \u2013 Experience in a referral centre in Mumbai, India. Abstract in IAL Biennial Conference, 2021."},{"key":"key-10.4103\/2229-5178.331156-12","first-page":"6656092","article-title":"Potential predictors of poor prognosis among severe COVID-19 patients: A single-center study","author":"Ghaith","year":"2021","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"key-10.4103\/2229-5178.331156-13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.47276\/lr.92.2.134","article-title":"Clinical findings in patients with leprosy who are infected with COVID-19: A case series from Elaz\u0131g\u0306, Turkey","author":"Dertliog\u0306lu","year":"2021","journal-title":"Lepr Rev"},{"key":"key-10.4103\/2229-5178.331156-14","doi-asserted-by":"crossref","first-page":"e0009019","DOI":"10.1371\/journal.pntd.0009019","article-title":"COVID-19, leprosy, and neutrophils","author":"Schmitz","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.4103\/2229-5178.331156-15","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ijid.2020.12.024","article-title":"Severe type 2 leprosy reaction with COVID-19 with a favourable outcome despite continued use of corticosteroids and methotrexate and a hypothesis on the possible immunological consequences","author":"Saxena","year":"2021","journal-title":"Int J Infect Dis"},{"key":"key-10.4103\/2229-5178.331156-16","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41586-021-03431-4","article-title":"Clofazimine broadly inhibits coronaviruses including SARS-CoV-2","author":"Yuan","year":"2021","journal-title":"Nature"},{"key":"key-10.4103\/2229-5178.331156-17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40360-021-00480-3","article-title":"Impact of previous exposure to systemic corticosteroids on unfavorable outcome in patients hospitalized for COVID-19","author":"Lafaurie","year":"2021","journal-title":"BMC Pharmacol Toxicol"},{"key":"key-10.4103\/2229-5178.331156-18","doi-asserted-by":"crossref","first-page":"e241105","DOI":"10.1136\/bcr-2020-241105","article-title":"Steroid harms if given early in COVID-19 viraemia","author":"Arora","year":"2021","journal-title":"BMJ Case Rep"},{"key":"key-10.4103\/2229-5178.331156-19","first-page":"693","article-title":"Dexamethasone in hospitalized patients with Covid-19","author":"RECOVERY","year":"2020","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2229-5178.331156-20","doi-asserted-by":"crossref","first-page":"116935","DOI":"10.1016\/j.jns.2020.116935","article-title":"Part II.high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced 'PANIC' attack","author":"Frohman","year":"2020","journal-title":"J Neurol Sci"},{"key":"key-10.4103\/2229-5178.331156-21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jaad.2020.04.085","article-title":"Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment","author":"Gisondi","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.331156-22","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41418-020-0530-3","article-title":"COVID-19 infection: The perspectives on immune responses","author":"Shi","year":"2020","journal-title":"Cell Death Differ"},{"key":"key-10.4103\/2229-5178.331156-23","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jaad.2020.06.999","article-title":"Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy","author":"Holcomb","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.331156-24","first-page":"151","article-title":"Use of colchicine in the management of erythema nodosum leprosum (ENL)","author":"Sarojini","year":"1983","journal-title":"Lepr Rev"},{"key":"key-10.4103\/2229-5178.331156-25","first-page":"43","article-title":"Colchicine in the treatment of type 2 lepra reaction","author":"Sharma","year":"1986","journal-title":"Indian J Lepr"},{"key":"key-10.4103\/2229-5178.331156-26","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s10067-020-05190-5","article-title":"Cytokine storm in COVID-19: Pathogenesis and overview of anti-inflammatory agents used in treatment","author":"Soy","year":"2020","journal-title":"Clin Rheumatol"},{"key":"key-10.4103\/2229-5178.331156-27","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s13063-020-04455-3","article-title":"Adding colchicine to the antiretroviral medication-lopinavir\/ritonavir (Kaletra) in hospitalized patients with non-severe Covid-19 pneumonia: A structured summary of a study protocol for a randomized controlled trial","author":"Dalili","year":"2020","journal-title":"Trials"},{"key":"key-10.4103\/2229-5178.331156-28","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/annrheumdis-2020-219174","article-title":"Anti-inflammatory therapy for COVID-19 infection: The case for colchicine","author":"Reyes","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"key-10.4103\/2229-5178.331156-29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.4103\/idoj.IDOJ_475_20","article-title":"Colchicine in dermatology: Rediscovering an old drug with novel uses","author":"Sardana","year":"2020","journal-title":"Indian Dermatol Online J","ISSN":"https:\/\/id.crossref.org\/issn\/2229-5178","issn-type":"print"},{"key":"key-10.4103\/2229-5178.331156-30","unstructured":"Erskine D. Using COVID-19 vaccines in a patient taking immunosuppressive medicines. 2021. Available from: https:\/\/www.sps.nhs.uk\/articles\/using-covid-19-vaccines-in-patient -taking-immunosuppressive-medicines\/. [Last acessed on 2021 May 18]."},{"key":"key-10.4103\/2229-5178.331156-31","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.jaad.2021.01.047","article-title":"An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology","author":"Gresham","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.331156-32","doi-asserted-by":"crossref","first-page":"e2000200","DOI":"10.1002\/bies.202000200","article-title":"Can BCG vaccine protect against COVID-19 via trained immunity and tolerogenesis?","author":"Basak","year":"2021","journal-title":"Bioessays"},{"key":"key-10.4103\/2229-5178.331156-33","first-page":"19","article-title":"Role of mycobacterium w for the treatment of COVID-19: An observational study","author":"Ingale","year":"2021","journal-title":"J Assoc Physicians India"},{"key":"key-10.4103\/2229-5178.331156-34","doi-asserted-by":"crossref","unstructured":"Sehgal IS, Guleria R, Singh S, Siddiqui MS, Agarwal R. A randomised trial of Mycobacterium w in critically ill patients with COVID-19 (ARMY-1). ERJ Open Res 2021;00059\u20132021. doi: 10.1183\/23120541.00059-2021.","DOI":"10.1183\/23120541.00059-2021"},{"key":"key-10.4103\/2229-5178.331156-35","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1590\/S0365-05962012000500017","article-title":"Mucormycosis and chromoblastomycosis occurring in a patient with leprosy type 2 reaction under prolonged corticosteroid and thalidomide therapy","author":"Bas\u00edlio","year":"2012","journal-title":"An Bras Dermatol"},{"key":"key-10.4103\/2229-5178.331156-36","doi-asserted-by":"crossref","first-page":"493","DOI":"10.4103\/idoj.idoj_406_21","article-title":"Emergence of Mucormycosis during COVID-19 pandemic and dermatological manifestations","author":"Vinay","year":"2021","journal-title":"Indian Dermatol Online J","ISSN":"https:\/\/id.crossref.org\/issn\/2229-5178","issn-type":"print"},{"key":"key-10.4103\/2229-5178.331156-37","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/qjmed\/hcx063","article-title":"Venous thrombo-embolism: Thalidomide and leprosy","author":"Chhabria","year":"2017","journal-title":"QJM"},{"key":"key-10.4103\/2229-5178.331156-38","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00011-020-01401-6","article-title":"The coagulopathy, endotheliopathy, and vasculitis of COVID-19","author":"Iba","year":"2020","journal-title":"Inflamm Res"},{"key":"key-10.4103\/2229-5178.331156-39","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.jaad.2018.04.048","article-title":"Thalidomide and thromboprophylaxis for dermatologic indications: An unmet need for more evidence","author":"Bishnoi","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.331156-40","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1346-8138.2011.01484.x","article-title":"Deep venous thrombosis and pulmonary embolism secondary to co-administration of thalidomide and oral corticosteroid in a patient with leprosy","author":"Yamaguchi","year":"2012","journal-title":"J Dermatol"},{"key":"key-10.4103\/2229-5178.331156-41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1590\/0037-8682-0216-2017","article-title":"Anti-phospholipid syndrome in seven leprosy patients with thrombotic events on corticosteroid and\/or thalidomide regimen: Insights on genetic and laboratory profiles","author":"Vernal","year":"2018","journal-title":"Rev Soc Bras Med Trop"},{"key":"key-10.4103\/2229-5178.331156-42","first-page":"1161","article-title":"Safety of major reconstructive surgery during the peak of the COVID-19 pandemic in the United Kingdom and Ireland-multicentre national cohort study","author":"Patel","year":"2020","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"key-10.4103\/2229-5178.331156-43","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.nrl.2020.04.002","article-title":"Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: A delayed pandemic?","author":"Serrano-Castro","year":"2020","journal-title":"Neurologia (Engl Ed)"},{"key":"key-10.4103\/2229-5178.331156-44","doi-asserted-by":"crossref","first-page":"100096","DOI":"10.1016\/j.bbih.2020.100096","article-title":"Changing dynamics of psychoneuroimmunology during the COVID-19 pandemic","author":"Debnath","year":"2020","journal-title":"Brain Behav Immun Health"},{"key":"key-10.4103\/2229-5178.331156-45","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3390\/healthcare8020168","article-title":"Examining social determinants of health, stigma, and COVID-19 disparities","author":"Turner-Musa","year":"2020","journal-title":"Healthcare (Basel)"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:29:51Z","timestamp":1787164191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_513_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"alternative-id":["331156"],"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_513_21","relation":{},"ISSN":["2229-5178"],"issn-type":[{"value":"2229-5178","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}